Guaifenesin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials